Antiretroviral therapy (ART) has resulted in a higher life expectancy of persons living with HIV. This has led to an aging population at risk for both non–AIDS-defining cancers (NADCs) and ...
Initiating antiretroviral therapy (ART) within 1 year of HIV infections was associated with a substantially lower risk for any non-AIDS-defining malignancy than later initiation. This protective ...
The intersection of HIV infection and lymphoma has long presented clinical challenges, with HIV-associated lymphomas comprising both AIDS-defining and non-AIDS-defining cancers. Recent advances in ...